However, MITD1 expression was lower in the tumor tissues of BRCA, esophageal carcinoma, kidney chromophobe (KICH), lung adenocarcinoma (LUAD), ovarian serous cystadenocarcinoma (OV), prostate adenocarcinoma (PRAD), skin cutaneous melanoma (SKCM), thyroid carcinoma (THCA), uterine corpus endometrial carcinoma (UCEC), uterine carcinosarcoma, adrenocortical carcinoma (ACC), and lung squamous cell carcinoma (LUSC) than in corresponding control tissues. Here, MITD1 is linked to prostate adenocarcinoma.